Systematic and Statistical Review of Coronavirus Disease 19 Treatment Trials.

Siordia, Juan A; Bernaba, Michael; Yoshino, Kenji; Ulhaque, Abid; Kumar, Sooraj; Bernaba, Mario; Bergin, Edward

Siordia, Juan A; Bernaba, Michael; Yoshino, Kenji; Ulhaque, Abid; Kumar, Sooraj; Bernaba, Mario; Bergin, Edward.

Afiliação

Siordia JA; Department of Medicine, Banner University Medical Center South Campus, 2800 E. Ajo Way, Tucson, AZ 85713 USA.
Bernaba M; Department of Medicine, Banner University Medical Center South Campus, 2800 E. Ajo Way, Tucson, AZ 85713 USA.
Yoshino K; Department of Medicine, Banner University Medical Center South Campus, 2800 E. Ajo Way, Tucson, AZ 85713 USA.
Ulhaque A; Department of Medicine, Banner University Medical Center South Campus, 2800 E. Ajo Way, Tucson, AZ 85713 USA.
Kumar S; Department of Medicine, Banner University Medical Center South Campus, 2800 E. Ajo Way, Tucson, AZ 85713 USA.
Bernaba M; Department of Medicine, Banner University Medical Center South Campus, 2800 E. Ajo Way, Tucson, AZ 85713 USA.
Bergin E; Department of Medicine, Banner University Medical Center South Campus, 2800 E. Ajo Way, Tucson, AZ 85713 USA.

SN Compr Clin Med ; 2(8): 1120-1131, 2020.

Article em En | MEDLINE | ID: mdl-32838169

Palavras-chave

Arbidol; COVID-19; Coronavirus; Dexamethasone; Favipiravir; Heparin; Hydroxychloroquine; Lopinavir/ritonavir; Remdesivir; SARS-CoV2; Tocilizumab; Treatment; Trials

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: SN Compr Clin Med Ano de publicação: 2020 Tipo de documento: Article